Showing results (1851-1860 of 1,979) with videos related to

Sort By:
Pageof 198
Plos One|September 17, 2010
Copy number analysis identifies novel interactions between genomic loci in ovarian cancerKylie L Gorringe, Joshy George, Michael S Anglesio, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2021
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR studyMichael Michael, Winston Liauw, Sue-Anne McLachlan, et al.
Ebiomedicine|March 17, 2015
Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviorsEtienne Cartier, Peter J Hamilton, Andrea N Belovich, et al.
Briefings in Bioinformatics|May 24, 2026
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screensShaine Chenxin Bao, Kathleen I Pishas, Karla J Cowley, et al.
Nature Neuroscience|February 9, 2016
Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicityNicholas L Weilinger, Alexander W Lohman, Brooke D Rakai, et al.
Journal of the National Cancer Institute|October 31, 2022
Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variantsBelle W X Lim, Na Li, Sakshi Mahale, et al.
Journal of Medical Genetics|February 10, 2023
Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen StudyJane M Tiller, Nicole E Cousens, Rajneesh Kaur, et al.
CBE Life Sciences Education|August 21, 2016
Improving Underrepresented Minority Student Persistence in STEMMica Estrada, Myra Burnett, Andrew G Campbell, et al.
Scientific Reports|January 17, 2020
Polycystin 2 is increased in disease to protect against stress-induced cell deathAllison L Brill, Tom T Fischer, Jennifer M Walters, et al.
British Journal of Cancer|February 22, 2023
TGFβ carrying exosomes in plasma: potential biomarkers of cancer progression in patients with head and neck squamous cell carcinomaNils Ludwig, Saigopalakrishna S Yerneni, Malgorzata Harasymczuk, et al.
Pageof 198